Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: University of Kentucky, Markey Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417019960
Cites:
Cited by:
Related to:
